Evidence map›Paper›PMID 39913357›Full record

ArticleJNCI cancer spectrum2025

Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance.

Christian Corsini, Pietro Scilipoti, Andri Wilberg Orrason, Rolf Gedeborg, Marcus Westerberg, Pär Stattin

Abstract readComparative Study
In one paragraph

Article in JNCI cancer spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christian CorsiniDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-9603-1589
Pietro ScilipotiDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0009-0007-6126-9889
Andri Wilberg OrrasonDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-2783-3542
Rolf GedeborgDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-8850-7863
Marcus WesterbergDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-8906-6967
Pär StattinDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Funding

Region UppsalaThe Swedish Cancer Society 22 2051The Swedish Research Council 2022-00544Uppsala University
6 · The paper itself

Abstract

backgroundIt is unknown if a period of active surveillance before prostatectomy for prostate cancer (PCa) worsens functional outcomes. The aim of this study was to compare functional outcomes after primary vs delayed robot-assisted radical prostatectomy.

methodsWe included men registered in the National Prostate Cancer Register of Sweden with low and favorable intermediate-risk PCa who underwent robot-assisted prostatectomy in 2018-2020 and had filled a questionnaire on patient-reported outcome measures. Multivariable logistic regression analysis was used to compare the functional outcomes of primary and delayed prostatectomy.

results2571 men underwent primary, and 921 men underwent delayed prostatectomy. Delayed prostatectomy was not associated with reduced overall quality of life (adjusted Odds Ratio [OR] 1.04; 95% confidence interval [CI] 0.71-1.55) or erectile dysfunction (adjusted OR 0.90, 95% CI 0.69-1.22). Urinary incontinence was slightly more common after delayed prostatectomy (15% vs 11%; adjusted OR 1.38, 95% CI 0.91-2.01). There were weak associations between time to prostatectomy and urinary symptoms and bother, with a 3% annual increase in the risk for urinary incontinence (adjusted OR 1.03; 95% CI 0.94-1.13).

conclusionThese results suggest that a period on active surveillance before robot-assisted radical prostatectomy has little detrimental effect on functional outcomes. Since only around half of men on active surveillance will transit to prostatectomy, these outcomes represent a worst-case scenario for men who start active surveillance. These results support the use of active surveillance for men with low-risk and favorable intermediate-risk PCa.

Indexed as

ProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresTime-to-TreatmentWatchful WaitingAgedErectile DysfunctionHumansLogistic ModelsMaleMiddle AgedPatient Reported Outcome MeasuresQuality of LifeRegistriesSwedenUrinary Incontinence

Identifiers

PMID39913357
PMCPMC11884805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.